Marvin Edeas - LinkedIn
A World-acknowledged Scientist - Marvin Edeas
As former Chair and a founder of the Mitochondria Society, Marvin Edeas (Linkedin) co-edits the group's publication and is Chair of its yearly congress. He chairs the worldwide conference "Targeting Microbiota and Mitochondria". Marvin Edeas chairs many committees, including that of the Congress on Targeting Mitochondria, Microbiota, Non-invasive Markers in Various Chronic Pathologies and Glycation & Maillard Reaction.
Works and Publications - Marvin Edeas
Marvin Edeas takes a close look at fields like mitochondria, microbiota and chronic diseases in many publications. There were two works of reference on mitochondrial medicine published by him in the year 2015. He has also authored literature aimed at the general public, for example, 'The Health Secrets of Tea' in 2005. Marvin Edeas has written a variety of publications and books.
Chair of the French Society (SFA) and International Society of Antioxidants (ISANH) and Founder of the World Mitochondria Society (WMS)
Research on mitochondria, microbiota, oxidative stress, inflammation, differentiation, cell signalling, Nrf2 transcription factors activation and their significance in various pathologies are the main focus of Marvin Edeas’ research. The connection between mitochondria and microbiota is his focus. The SFA is dedicated to boosting the usage of antioxidants in health and nutrition, including their use in preventative and therapeutic medicine. He is founder and Chair of the International Society of Antioxidants in Nutrition & Health (ISANH) which was formed in '98. The established French Society of Antioxidants (SFA) is a society which Marvin Edeas chairs.
Very real uses have been found for the developments made by Marvin Edeas. Thanks to these patents, a start-up company was formed in order to market the new peptide. Cosmetology, dietetics and medicine could all possibly reap benefits from Oyster hydrolyzate.
Marvin Edeas took part in the earliest clinical study on the effects of antiretroviral therapy on lactic acidosis and hyperlactatemia. In the 1990s, Marvin Edeas conducted extensive research on the AIDS virus. The latency mechanisms of HIV in HIV-positive patients, including the activation factors, is a field which he spent six years studying at the Antoine Béclère Hospital.